The US Bankruptcy Court approved the combined hearing to consider approval of disclosure statement and plan of Sorrento Therapeutics, Inc. on October 18, 2023. The debtor had filed its disclosure statement and plan in the Court on October 11, 2023. The voting record date is October 18, 2023.

The deadline to vote on the plan is November 10, 2023. Any objections to the plan should be made before November 10, 2023 and the confirmation hearing for the plan and disclosure statement has been scheduled for November 20, 2023.